首页> 美国卫生研究院文献>BMC Pharmacology Toxicology >Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions
【2h】

Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions

机译:奥昔布宁和托特罗定在不同膀胱造影条件下对清醒和麻醉大鼠的尿动力学影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAntimuscarinic agents are the most popular treatment for overactive bladder and their efficacy in man is well documented, producing decreased urinary frequency and an increase in bladder capacity. During cystometry in rats, however, the main effect reported after acute treatment with antimuscarinics is a decrease in peak micturition pressure together with little or no effect on bladder capacity. In the present experiments we studied the effects, in rats, of the two most widely used antimuscarinic drugs, namely oxybutynin and tolterodine, utilising several different cystometrographic conditions. The aim was to determine the experimental conditions required to reproduce the clinical pharmacological effects of antimuscarinic agents, as seen in humans, in particular their ability to increase bladder capacity.
机译:背景抗毒蕈碱剂是膀胱过动症最流行的治疗方法,其在人体中的功效已得到充分证明,可降低尿频并增加膀胱容量。然而,在大鼠膀胱测压期间,抗毒蕈碱药物急性治疗后报道的主要作用是排尿峰值压力降低,并且对膀胱容量几乎没有影响。在本实验中,我们利用几种不同的膀胱造影条件,研究了大鼠中两种最广泛使用的抗毒蕈碱药物,即奥昔布宁和托特罗定的作用。目的是确定重现抗毒蕈碱剂的临床药理作用所需的实验条件,如在人体中所见,尤其是其增加膀胱容量的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号